Subject
Clinical Neurology,Neurology,General Medicine
Reference26 articles.
1. Adherence to disease-modifying therapies and its impact on relapse, health resource utilization, and costs among patients with Multiple Sclerosis;Burks;ClinicoEcono. Outcomes Res.,2017
2. A retrospective, observational study comparing the four available immunomodulatory treatments for relapsing–remitting Multiple Sclerosis;Carra;Eur. J. Neurol.,2003
3. Relapse and disability outcomes in patients with multiple sclerosis treated with fingolimod: subgroup analyses of the double-blind, randomised, placebo-controlled freedoms study;Devonshire;Lancet Neurol.,2012
4. Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting Multiple Sclerosis;Ebers;Lancet North Am. Ed.,1998
5. Impact of adherence on subcutaneous interferon beta-1a effectiveness administered by Rebismart® in patients with Multiple Sclerosis;Edo-Solsona;Patient Prefer. Adherence,2017
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献